Table 2.

TTE measurements in controls, AFMR group, and VFMR group

	Control group (n = 36)	AFMR group (n = 36)	VFMR group (n = 32)	P-value
LV, mm	46.5 ± 2.5	47.5 ± 5.0	54.4 ± 8†‡	0.001
LA, mm	32.4 ± 4.2	44.6 ± 7.3†	48.4 ± 9.0†	0.001
LA maximum volume, mL	41.0 ± 14.2	103.7 ± 45.3†	120.8 ± 64.2†	0.001
LA maximum volume index, mL/m2	22.2 ± 7.3	58.4 ± 27.6†	66.9 ± 34.4†	0.001
LA minimum volume, mL	17.3 ± 8.3	77.0 ± 39.8†	96.0 ± 58.6†	0.001
LAEF, %	59.2 ± 7.1	29.9 ± 8.7†	26.8 ± 8.9†	0.000
LVEDV, mL	100.2 ± 12.9	106.6 ± 27.4	132.2 ± 40.3†‡	0.001
LVESV, mL	33.3 ± 6.5	39.1 ± 13.3	74.5 ± 29.7†‡	0.001
LV EDV/BSA, mL/m2	54.3 ± 4.7	59.3 ± 13.9	72.7 ± 22.0†‡	0.001
LV ESV/BSA, mL/m2	18.0 ± 3.0	21.7 ± 6.8	40.8 ± 15.8†‡	0.001
LVEF, %	67 ± 4	64 ± 5	43 ± 8†‡	0.001
E/E’ septal	9.9 ± 3	14.9 ± 4.4†	14.6 ± 4.7†	0.001
MR regurgitation volume, mL		18(15,22)	20(15,25)	0.516

Results are shown as the mean ± SD or median (interquartile range). *Three and two groups were statistically compared using a one-way ANOVA with post hoc Bonferroni test. †P < 0.05 vs. control; ‡P < 0.05 vs. AFMR patients. MR, mitral regurgitation